Le Lézard
Classified in: Health
Subject: NEW PRODUCTS/SERVICES

Helping save lives: 2,300 teachers received the Opioid Overdose Response Training to teach high school students how to react when facing a suspected opioid overdose


OTTAWA, May 09, 2024 (GLOBE NEWSWIRE) -- The Advanced Coronary Treatment (ACT) Foundation announced today it has completed Phase 1 of its Opioid Overdose Response Training (OORT). As a result, 2,300 teachers from 830 high schools in Canada are now equipped to teach their students in how to respond to a suspected opioid overdose.

The training allows teachers to teach students:        

The Opioid Overdose Response Training module, launched in 2022, is an enhancement to the ACT Foundation's successful high school cardiopulmonary resuscitation (CPR) and automated external defibrillator (AED) program, free for high schools.

Thanks to the number of teachers trained with the OORT so far, more than 160,000 students each year could be empowered to respond to a suspected opioid overdose as part of their CPR and AED training in high schools.

The ACT Foundation received a contribution from Health Canada's Substance Use and Addictions Program (SUAP) from January 2021 to March 2024. This contribution was in support of the development and implementation of the module on Opioid Overdose Response Training in Canadian provinces where the ACT Foundation has widely established the High School CPR and AED Program.

According to the Public Health Agency of Canada, 5,975 apparent opioid toxicity deaths were reported from January to September 2023. The Canadian Centre on Substance Use and Addiction notes the majority (94%) of opioid overdose deaths happen by accident, and young Canadians aged 15 to 24 are the fastest-growing population requiring hospital care from opioid overdoses.

"The landscape of emergency response is changing in Canada due to the increase of opioid overdoses and, as a society, we all have a role to play," says Sandra Clarke, the ACT Foundation's Executive Director. "Enhancing ACT's High School CPR and AED Program with opioid awareness and response training is an important step in empowering youth to respond to life-threatening emergencies. We are happy for the achievement of this milestone, but we are far from being done. Yes, Phase 1 is completed, but we want to reach more students. Our trainings need public and private partners committed to help ACT to expand its programs to more high schools in Canada."

"The opioid crisis is a complex issue and causes many of the opioid-related harms and deaths. ACT's response to this crisis provides high school teachers with the tools to add the Opioid Overdose Response Training to the current CPR training, enhancing students' lifesaving toolbox. Recognizing a suspected opioid overdose and knowing how to respond can help save lives," says Dr. Michael Austin, ACT's National Medical Director.

ACT's overall goal is to see every high school student across Canada graduate with the confidence, skills, and knowledge to save a life. To help achieve this goal, ACT receives the financial support from private and public organizations who believe in the positive impact ACT can play in Canada's society.

"As a founding partner of the ACT Foundation, we are proud of the incredible impact being made to empower youth across Canada with critical life-saving skills, including the Opioid Overdose Response Training," says Gaby Bourbara, President, AstraZeneca Canada. "On behalf of AstraZeneca Canada, we congratulate the ACT Foundation for achieving today's milestone, helping to build stronger, healthier communities."

"On behalf of all the staff at Amgen Canada, I want to congratulate the ACT Foundation for the completion of Phase 1 of its Opioid Overdose Response Training. ACT is a pioneer in establishing free CPR and AED training in high schools in Canada and I am confident that this announcement is just the beginning of the expansion of ACT's footprint when it comes to supporting youth," mentions Ugur Gunaydin, Vice-President and General Manager, Amgen Canada.

About the ACT Foundation
The ACT Foundation is the national charitable organization establishing free CPR and AED training in Canadian high schools, and how to respond to a suspected opioid overdose, a new aspect of the program. The program is built on ACT's award-winning, community-based model of partnerships and support, whereby ACT finds partners who donate the mannequins and AED training units that schools need to deliver the program. High school teachers are trained to then teach lifesaving skills to their students as a regular part of the curriculum, reaching all youth prior to graduation. The ACT High School CPR and AED Program is made possible with the support of its national health partners, AstraZeneca Canada and Amgen Canada, and provincial and community partners. The ACT Foundation gratefully acknowledges the contribution of Health Canada's Substance Use and Addictions Program (SUAP) for the ACT Opioid Overdose Response Training program.

Website: actfoundation.ca
Twitter: @actfoundation #ACT2Save
Facebook: @theactfoundation
Instagram: @theactfoundation
YouTube: YouTube.com/theactfoundation

For more information about the ACT Foundation and the ACT Opioid Overdose Response Training, contact:

Christian Ahuet
Director, Health and Life Sciences
NATIONAL Public Relations
[email protected]
Tel: 514-994-7496
Jennifer Russell
Director of Operations
ACT Foundation
[email protected]
Cell: 613-286-5260
  

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/814ad809-e164-4ce7-8250-d143c2b6faf5



These press releases may also interest you

at 04:45
ERS Genomics Limited (?ERS'), the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS' CRISPR/Cas9 patent portfolio....

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....



News published on and distributed by: